![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, November 09, 2015 10:05:22 AM
Read more: http://www.dailymail.co.uk/sciencetech/article-2802476/the-mini-incubator-halve-cost-ivf-champagne-cork-device-thousands-women-chance-motherhood.html#ixzz3r0TDXouj
Follow us: @MailOnline on Twitter | DailyMail on Facebook
Excerpts
‘We are trying to simplify the whole process – what we like to call effortless IVF.’
In a conventional IVF lab, fledgling embryos are kept in expensive incubators for up to five days before the best ones are put into the woman’s body.
This is costly. The incubators cost tens of thousands of pounds each and have to be constantly monitored to make sure they are working properly, are at the right temperature and contain the right mix of gases for the delicate embryos to grow.
The INVOcell technique lowers costs by doing away with the incubators and the need for constant monitoring.
The early-stage embryos are instead nurtured inside a clear plastic device of roughly the same size and shape as a champagne bottle cork.
This is placed inside the woman’s vagina, which is at the right temperature and contains the right mix of carbon dioxide and oxygen for growth.
Nine babies have so far been born using the new, cheaper, IVF technique.
After three to five days, it is removed and the best embryos transferred to the woman’s womb as usual.
Costs are also cut by giving lower doses of the powerful drugs used to boost egg production ahead of IVF.
Lower doses also mean that a woman needs to make fewer visits to the IVF clinic to check the drugs are working properly.
So rather than taking time off work for ten trips to her doctor, she only needs three appointments.
In a study of 33 infertile women, pregnancy rates were the same among those who used INVOcell as those whose embryos were nurtured in incubators.
Dr Doody, of the Center for Assisted Reproduction in Bedford, Texas, said: ‘We are amazed that we could grow beautiful, top-quality embryos without the complexity of an incubator.’
His wife, Dr Kathleen Doody, said: ‘We definitely had feedback from patients that it seemed more natural to them.’
It is hoped that by simplifying the process, it will be possible to provide IVF from mobile units, making it more accessible for those who don’t live in big towns and cities.
Dr Doody, who has shares in the device’s manufacturer, Massachusetts-based INVO Bioscience, said that while it won’t be suitable for all women, it could help up to two-thirds of patients.
The device may also make IVF more acceptable to the Catholic Church, which disapproves of IVF because fertilisation takes place outside the body and in a dish.
With INVOcell, fertilisation takes place once the device is inside the woman’s body.
Read more: http://www.dailymail.co.uk/sciencetech/article-2802476/the-mini-incubator-halve-cost-ivf-champagne-cork-device-thousands-women-chance-motherhood.html#ixzz3r0TDXouj
Follow us: @MailOnline on Twitter | DailyMail on Facebook
Recent INVO News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/21/2024 08:39:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:51:16 PM
- INVO Reports Record First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/15/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:30:18 PM
- Micro Cap Massively Bid Up Before Opening Bell • AllPennyStocks.com • 04/17/2024 02:25:00 PM
- INVO Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/16/2024 08:59:29 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 03:24:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 02:01:07 PM
- NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON) • GlobeNewswire Inc. • 01/23/2024 01:00:00 PM
- INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors • GlobeNewswire Inc. • 01/17/2024 01:00:00 PM
- Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 01/16/2024 10:29:59 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/10/2024 09:46:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:05:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:29:45 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 12/28/2023 10:04:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 10:02:41 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/13/2023 10:08:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 09:53:21 PM
- NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal • PR Newswire (US) • 12/11/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 10:18:38 PM
- INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement • PR Newswire (US) • 11/28/2023 02:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/24/2023 06:08:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:59:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:10:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:06:04 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM